# Carolina Reis Oliveira

> Carolina Reis Oliveira is the Brazilian scientist, co-founder, and CEO of OneSkin, a San Francisco company that turned a lab-built screening platform into a consumer brand. Trained in biochemistry, immunology, stem-cell biology, and tissue engineering, she first co-founded CellSeq in Brazil to develop human-tissue testing alternatives, joined IndieBio in 2016, and then helped build OneSkin with fellow scientists Alessandra Zonari, Mariana Boroni, and Juliana Carvalho. The company spent years screening more than 900 peptides before commercializing OS-01, launched its first product in 2021, earned Fast Company recognition in 2024, and announced a $20 million investment from Prelude Growth Partners in 2025.

- **Role:** Co-founder and CEO at OneSkin
- **Organizations:** OneSkin, CellSeq Solutions, IndieBio, Endeavor
- **From:** Conselheiro Lafaiete, Brazil
- **Nationality:** Brazilian
- **Education:** Bachelor's degree in Biochemistry, Universidade Federal de Viçosa, Master's degree in Biochemistry and Immunology, Universidade Federal de Minas Gerais, PhD in Biochemistry and Immunology, focused on stem-cell biology and tissue engineering, Universidade Federal de Minas Gerais, Visiting PhD research in stem-cell biology, Rutgers University
- **Known for:** Co-founded OneSkin with a team of Brazilian PhD scientists and has served as its CEO since 2016., Led the transition from a business-to-business tissue-testing concept to a direct-to-consumer biotechnology brand., Helped oversee a research program that screened more than 900 peptides before selecting OS-01.

## Career timeline

- **2009** — Completed undergraduate study in biochemistry at Universidade Federal de Viçosa.
- **2011** — Completed a master's degree in biochemistry and immunology at Universidade Federal de Minas Gerais.
- **2012-2013** — Conducted visiting doctoral research at Rutgers University.
- **2014** — Co-founded CellSeq Solutions in Brazil, working on human-cell models and alternatives to animal testing.
- **2015** — Completed doctoral work at Universidade Federal de Minas Gerais focused on stem-cell biology and tissue engineering.
- **2016** — Relocated to Silicon Valley, joined IndieBio, and co-founded OneSkin.
- **2021** — OneSkin launched its first consumer product after roughly five years of research and development.
- **2023** — OneSkin researchers published peer-reviewed work on the OS-01 peptide in npj Aging.
- **2024** — OneSkin was named one of Fast Company's Most Innovative Companies in the beauty category; Oliveira and Alessandra Zonari were selected as Endeavor Entrepreneurs.
- **2025** — OneSkin announced a $20 million investment from Prelude Growth Partners.
- **2026** — Oliveira was named to the Inc. Female Founders 500 and continued speaking at business and beauty industry events.

## Achievements

- Co-founded OneSkin with a team of Brazilian PhD scientists and has served as its CEO since 2016.
- Led the transition from a business-to-business tissue-testing concept to a direct-to-consumer biotechnology brand.
- Helped oversee a research program that screened more than 900 peptides before selecting OS-01.
- Co-inventor on at least five patents, according to her Endeavor profile.
- Co-author of peer-reviewed research in regenerative medicine, skin biology, and aging.
- Selected with Alessandra Zonari as an Endeavor Entrepreneur in 2024.
- Led OneSkin through a 2024 Series A close and a separate $20 million Prelude Growth Partners investment announced in 2025.
- Named to the Inc. Female Founders 500 in 2026.

## Latest updates

- **2026-06** — Shared OneSkin's San Francisco event bringing together speakers to discuss longevity science and introducing Bare Blush Lip Shield.
- **2026-05** — Named to the Inc. Female Founders 500 as OneSkin marked its tenth anniversary year.
- **2026-03** — Spoke at the BeautyMatter FUTURE50 Summit in New York.
- **2026-02** — Participated in the LatAm Business Forum at UC Berkeley Haas.
- **2025-08** — OneSkin announced a $20 million investment from Prelude Growth Partners, completed the prior month.
- **2025-04** — Co-authored a pilot clinical study published in the Journal of Cosmetic Dermatology.

## Links

- Website: https://www.oneskin.co
- LinkedIn: https://www.linkedin.com/in/carolina-reis-oliveira-a69b8a27
- YouTube: https://www.youtube.com/watch?v=k_bJgAKt7k4
- Instagram: https://www.instagram.com/caroll_reis/

---

Profile page: https://yespress.io/carolina-oliveira
Published by YesPress — https://yespress.io
Last updated: 2026-08-18